Literature DB >> 1374586

Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody.

A Hameed1, K J Olsen, L Cheng, W M Fox, R H Hruban, E R Podack.   

Abstract

Perforin is a potent cytolytic pore-forming protein expressed in cytoplasmic granules of cytotoxic T lymphocytes and natural killer cells. A new monoclonal antibody raised against human perforin was used to detect both in vitro and in vivo perforin expression in cytotoxic cells. Immunohistochemical analysis of human peripheral blood mononuclear cells cultured in recombinant interleukin-2 (rIL-2) showed strong granular cytoplasmic staining of the IL-2 activated cytotoxic cells. Fresh-frozen tissue sections from patients with heart allograft rejection were also stained. Strong granular cytoplasmic staining of the mononuclear inflammatory infiltrate characteristic for perforin in cardiac allograft rejection was observed. The detection and quantitative analysis of perforin-associated cytotoxic cells by the human anti-perforin monoclonal antibody will help to evaluate the significance of these functionally distinct cytotoxic cells in human tissue.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374586      PMCID: PMC1886520     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

Authors:  M E Billingham; N R Cary; M E Hammond; J Kemnitz; C Marboe; H A McCallister; D C Snovar; G L Winters; A Zerbe
Journal:  J Heart Transplant       Date:  1990 Nov-Dec

2.  Perforin gene expression in granular lymphocyte proliferative disorders.

Authors:  K Oshimi; Y Shinkai; K Okumura; Y Oshimi; H Mizoguchi
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

Review 3.  Cytotoxic T lymphocyte mediated cytolysis.

Authors:  J Tschopp; C V Jongeneel
Journal:  Biochemistry       Date:  1988-04-19       Impact factor: 3.162

4.  Structure and function of human perforin.

Authors:  M G Lichtenheld; K J Olsen; P Lu; D M Lowrey; A Hameed; H Hengartner; E R Podack
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

5.  Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes.

Authors:  O Krähenbühl; C Rey; D Jenne; A Lanzavecchia; P Groscurth; S Carrel; J Tschopp
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

6.  Inhibition of NK and ADCC activity by antibodies against purified cytoplasmic granules from rat LGL tumors.

Authors:  C W Reynolds; D Reichardt; M Henkart; P Millard; P Henkart
Journal:  J Leukoc Biol       Date:  1987-12       Impact factor: 4.962

7.  Isolation and characterization of cytotoxic granules from human lymphokine (interleukin 2) activated killer cells.

Authors:  D M Lowrey; A Hameed; M Lichtenheld; E R Podack
Journal:  Cancer Res       Date:  1988-08-15       Impact factor: 12.701

8.  Identification and characterization of a pore-forming protein of human peripheral blood natural killer cells.

Authors:  C C Liu; B Perussia; Z A Cohn; J D Young
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

9.  Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A.

Authors:  C C Liu; S Rafii; A Granelli-Piperno; J A Trapani; J D Young
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Cytolysis by Ca-permeable transmembrane channels. Pore formation causes extensive DNA degradation and cell lysis.

Authors:  A Hameed; K J Olsen; M K Lee; M G Lichtenheld; E R Podack
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  13 in total

1.  Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain.

Authors:  R Uellner; M J Zvelebil; J Hopkins; J Jones; L K MacDougall; B P Morgan; E Podack; M D Waterfield; G M Griffiths
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

2.  Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis.

Authors:  N Goebels; D Michaelis; M Engelhardt; S Huber; A Bender; D Pongratz; M A Johnson; H Wekerle; J Tschopp; D Jenne; R Hohlfeld
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

3.  Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease.

Authors:  Z Wu; E R Podack; J M McKenzie; K J Olsen; M Zakarija
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

4.  Characterization of a novel monoclonal antibody against human perforin using transfected cell lines.

Authors:  B C Schlesinger; L Cheng
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

5.  Cytotoxic potential of intraepithelial lymphocytes (IELs). Presence of TIA-1, the cytolytic granule-associated protein, in human IELs in normal and diseased intestine.

Authors:  G J Russell; C Nagler-Anderson; P Anderson; A K Bhan
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

6.  Angiocentric lymphoma with granulomatous panniculitis in the skin expressing natural killer cell and large granular T-cell phenotypes.

Authors:  M Takeshita; N Kimura; J Suzumiya; K Ohshima; M Kikuchi; R Watanabe; T Okamura; H Goto
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures.

Authors:  I Vollenweider; R Moser; P Groscurth
Journal:  Cancer Immunol Immunother       Date:  1994-11       Impact factor: 6.968

8.  Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease.

Authors:  Joanne Filicko-O'Hara; Dolores Grosso; Phyllis R Flomenberg; Thea M Friedman; Janet Brunner; William Drobyski; Andres Ferber; Irina Kakhniashvili; Carolyn Keever-Taylor; Bijoyesh Mookerjee; Julie-An Talano; John I Wagner; Robert Korngold; Neal Flomenberg
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-08       Impact factor: 5.742

9.  Identification of an astrocyte cell population from human brain that expresses perforin, a cytotoxic protein implicated in immune defense.

Authors:  P Gasque; J Jones; S K Singhrao; B Morgan
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

10.  Perforin expression in peripheral blood lymphatic cells of patients subjected to laparoscopic or open cholecystectomy.

Authors:  Harry Grbas; Ines Mrakovcić-Sutić; Arsen Depolo; Biserka Radosević-Stasić
Journal:  Mediators Inflamm       Date:  2009-05-07       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.